MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors. - Cros, J.; Hentic, O.; Rebours, V.; Zappa, M.; Gille, N.; Theou-Anton, N.; Vernerey, D.; Maire, F.; Lévy, P.; Bedossa, P.; Paradis, V.; Hammel, P.; et al. (Endocrine-Related Cancer, 2016)